Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 456.97B | 505.98B | 430.16B | 311.12B | 315.39B |
Gross Profit | 42.32B | -157.00M | 32.71B | 22.79B | 20.06B |
EBITDA | 36.88B | -2.03B | 21.34B | -5.29B | 10.33B |
Net Income | 26.99B | -15.83B | 15.19B | -12.63B | 7.99B |
Balance Sheet | |||||
Total Assets | 461.03B | 426.97B | 406.59B | 395.40B | 329.58B |
Cash, Cash Equivalents and Short-Term Investments | 307.28B | 102.07B | 61.24B | 68.80B | 106.99B |
Total Debt | 23.60B | 23.60B | 29.09B | 45.62B | 45.75B |
Total Liabilities | 435.57B | 420.89B | 384.28B | 379.64B | 292.84B |
Stockholders Equity | 23.71B | 4.86B | 22.18B | 15.65B | 36.40B |
Cash Flow | |||||
Free Cash Flow | 55.97B | 58.86B | 41.37B | -27.73B | -22.95B |
Operating Cash Flow | 57.66B | 62.75B | 44.16B | -25.59B | -20.81B |
Investing Cash Flow | -4.18B | -1.57B | 7.89B | -3.79B | -2.25B |
Financing Cash Flow | -298.00M | -5.85B | -17.06B | -4.20B | 9.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Neutral | $96.34B | 3.26 | 150.62% | ― | -12.80% | ― | |
58 Neutral | HK$13.91B | 4.82 | -3.70% | 5.62% | 2.15% | -62.33% | |
― | $2.33B | ― | -1.77% | 2.70% | ― | ― | |
84 Outperform | ¥83.83B | 10.39 | 4.01% | 3.55% | 36.89% | ||
82 Outperform | ¥76.29B | 9.76 | 2.53% | 4.24% | 22.05% | ||
74 Outperform | ¥104.01B | 15.83 | 2.05% | 7.26% | 29.33% | ||
69 Neutral | ¥103.19B | 16.48 | 2.44% | 6.90% | -25.24% |